Functional mechanism of ASP5736, a selective serotonin 5-HT5A receptor antagonist with potential utility for the treatment of cognitive dysfunction in schizophrenia

被引:9
作者
Yamazaki, Mayako [1 ]
Yamamoto, Noriyuki [1 ]
Yarimizu, Junko [1 ]
Okabe, Mayuko [1 ]
Moriyama, Ai [2 ]
Furutani, Masako [2 ]
Marcus, Monica M. [3 ]
Svensson, Torgny H. [3 ]
Harada, Katsuya [1 ]
机构
[1] Astellas Pharma Inc, Dept Neurosci, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan
[2] Astellas Pharma Inc, Anal & Pharmacokinet Res, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan
[3] Karolinska Inst, Sect Neuropsychopharmacol, Dept Physiol & Pharmacol, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
5-HT5(A) receptor; antagonist; Schizophrenia; Cognition; Immunohistochemisry; Microdialysis; Electrophysiological studies; VENTRAL TEGMENTAL AREA; PCP-INDUCED DEFICITS; PREFRONTAL CORTEX; DOPAMINERGIC-NEURONS; WORKING-MEMORY; FRONTAL-CORTEX; PHENCYCLIDINE; REVERSAL; NUCLEUS; MICE;
D O I
10.1016/j.euroneuro.2018.03.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The 5-HT5A receptor is arguably the least understood 5-HT receptor. Despite widespread expression in human and rodent brains it lacks specific ligands. Our previous results suggest that 5-HT5A receptor antagonists may be effective against cognitive impairment in schizophrenia. In this study, using behavioral, immunohistochemical, electrophysiological and microdialysis techniques, we examined the mechanism by which ASP5736, a novel and selective 5-HT5A receptor antagonist, exerts a positive effect in animal models of cognitive impairment. We first confirmed the effect of ASP5736 on cognitive deficits in rats treated subchronically with phencyclidine hydrochloride (PCP) using an attentional set shifting task. Subsequently, we identified 5-HT5A receptors in dopaminergic (DAergic) neurons and parvalbumin (PV)-positive interneurons in the ventral tegmental area (VTA) and in PV-positive interneurons in the medial prefrontal cortex (mPFC). Burst firing of the DAergic cells in the parabrachial pigmental nucleus (PBP) in the VTA, which predominantly project to the mPFC, was significantly enhanced by treatment with ASP5736. In contrast, ASP5736 exerted no significant effect on either the firing rate or burst firing in the DA cells in the paranigral nucleus (PN), that project to the nucleus accumbens (N. Acc.). ASP5736 increased the release of DA and gamma-aminobutyric acid (GABA) in the mPFC of subchronically PCP-treated rats. These results support our hypothesis that ASP5736 might block the inhibitory 5-HT5A receptors on DAergic neurons in the VTA that project to the mPFC, and interneurons in the mPFC, and thereby improve cognitive impairment by preferentially enhancing DAergic and GABAergic neurons in the mPFC. (C) 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/hcenses/by-nc-nd/4.0/).
引用
收藏
页码:620 / 629
页数:10
相关论文
共 55 条
[31]  
Mathé JM, 1998, J NEUROSCI RES, V51, P583, DOI 10.1002/(SICI)1097-4547(19980301)51:5<583::AID-JNR5>3.0.CO
[32]  
2-B
[33]   The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia [J].
Nikiforuk, Agnieszka ;
Holuj, Maigorzata ;
Kos, Tomasz ;
Popik, Piotr .
NEUROPHARMACOLOGY, 2016, 105 :351-360
[34]   Localization of 5-ht5A receptor-like immunoreactivity in the rat brain [J].
Oliver, KR ;
Kinsey, AM ;
Wainwright, A ;
Sirinathsinghji, DJS .
BRAIN RESEARCH, 2000, 867 (1-2) :131-142
[35]   Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage [J].
Pantelis, C ;
Barber, FZ ;
Barnes, TRE ;
Nelson, HE ;
Owen, AM ;
Robbins, TW .
SCHIZOPHRENIA RESEARCH, 1999, 37 (03) :251-270
[36]   Distribution of the 5-HT5A serotonin receptor mRNA in the human brain [J].
Pasqualetti, M ;
Ori, M ;
Nardi, I ;
Castagna, M ;
Cassano, GB ;
Marazziti, D .
MOLECULAR BRAIN RESEARCH, 1998, 56 (1-2) :1-8
[37]   Chronic infusion of PCP via osmotic mini-pumps: A new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance [J].
Pedersen, Christian Spang ;
Goetghebeur, Pascal ;
Dias, Rebecca .
JOURNAL OF NEUROSCIENCE METHODS, 2009, 185 (01) :66-69
[38]   CLONING AND CHARACTERIZATION OF THE HUMAN 5-HT5A SEROTONIN RECEPTOR [J].
REES, S ;
DENDAAS, I ;
FOORD, S ;
GOODSON, S ;
BULL, D ;
KILPATRICK, G ;
LEE, M .
FEBS LETTERS, 1994, 355 (03) :242-246
[39]   Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist:: Comparison among antipsychotics [J].
Rodefer, Joshua S. ;
Nguyen, Tuyet N. ;
Karlsson, Jens-Jakob ;
Arnt, Jorn .
NEUROPSYCHOPHARMACOLOGY, 2008, 33 (11) :2657-2666
[40]   PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats [J].
Rodefer, JS ;
Murphy, ER ;
Baxter, MG .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 21 (04) :1070-1076